Introduction
Marfan syndrome is a disorder of connective tissue showing autosomal dominant inheritance and wide clinical variability. The estimated prevalence is about 4-6 per 100,000 persons.' Classically abnormalities occur in the cardiovascular and musculoskeletal systems, and the eyes. With the advent of stricter diagnostic criteria2 it has become possible to evaluate patients with Marfan syndrome more critically. Because Marfan syndrome is a disorder of connective tissue it has long been thought to predispose to osteoporosis. Authoritative texts list Marfan syndrome as a cause ofosteoporosis3-5 and clinician guidelines from the National Osteoporosis Foundation5 imply that it is a cause. The aim of our study was to evaluate, by measurement of forearm bone mass, the presence of osteoporosis in volunteer patients known to suffer from Marfan syndrome as diagnosed by strict criteria.2 The only earlier study, by Brenton et al.,6 lacked the clear clinical diagnostic criteria now available and used only the relatively crude technique of spinal radiography for the assessment of osteoporosis.
Methods
The patients met the criteria ofthe Berlin Nosology (Table I) 'distal' (DBMC) measurements are at a site comprising approximately 50% trabecular bone and the 'proximal' (PBMC) site comprises approximately 90% cortical bone.8 BMC values were divided by bone width at the measurement site to provide an index of bone density (DBMC/BW and PBMC/BW). The precision of the bone mineral content estimations was assessed by two operators carrying out the procedure on one healthy female volunteer (age 23) on 10 occasions at approximately weekly intervals. The coefficients of variation were 1.3% for distal BMC (mean 28.5) and 1.2% for proximal BMC (mean 32.2). There were no significant differences between the two operators.
Baseline BMC measurements were expressed as 'z' scores: the number of standard deviations (s.d.) of the patient's value from the age and sex-adjusted mean ofa local reference population. The reference interval ( ± 2s.d. from the mean) was calculated for each sex from BMC measurements on normal subjects aged between 20 and 80 (91 men in 10 year age groups and 286 women in 5 year age groups). Differences between the Marfan syndrome patients and the control subjects were analysed by Student's t-test.
Results Figure 1 illustrates the distribution of sample results as the number of standard deviations from the mean for an age-and sex-matched population. The female results marked with an asterisk came from one individual who had been immobilized by vertebral crush-fractures due to long-term oral steroid therapy. The other three female patients had a DBMC/BW measurement within the reference interval for age and sex. All the DBMC/BW measurements for the males were within the reference interval and 60% were within one standard deviation (Figure 1 ).
Discussion
In 1972 Brenton et al. compared a series of 22 cases of homocystinuria with 16 cases of Marfan syndrome. 6 The diagnostic criteria were much less precise than those currently accepted and used in this present study. The age range in Brenton's 'Marfan' patients was from 5 years 7 months to 31 years 11 months; we felt that our study should be limited to adults for whom a well-documented local reference population was available. 
FEMALE (n=4)
MALE (n=10) Using the relatively crude technique of spine radiology, Brenton concluded that none of the 'Marfan' patients had osteoporosis, whilst half of the homocystinuria patients showed 'moderate' or 'severe' osteoporotic changes.
Despite the conclusion of this earlier paper we found several examples of authoritative current literature referring to Marfan syndrome as a cause of osteoporosis. Using more precise techniques, an age range for whom good control data was available, and the current stricter diagnostic guidelines, we present data that suggest that osteoporosis is not a significant problem in the patients we studied. The male patients showed no evidence of reduction in bone mass. The number of females studied to date was small, and results were influenced by the low bone mineral content of one patient who had received long-term oral steroid therapy and suffered long periods of immobility.
Our results imply that there is no evidence that osteoporosis is a feature of Marfan syndrome patients. However, we recognize that our study was carried out with measurements only at the radius. Several studies have shown that measurement at this site is as good as measurement of spinal bone mass for prediction for future fractures.9"0 It is hoped that further study using dual energy X-ray densitometry of the spine and hips which is planned, will clarify the question of osteoporosis.
The findings were not artefacts resulting from the long slender bones ofthe Marfan patient's since the results were comfortably normal whether or not divided by bone width (BW). It is likely that earlier confusion arose because of the difficulties in diagnosing Marfan syndrome and in distinguishing it from clinically similar syndromes such as homocystinuria.
